Department of Pharmacology and Toxicology and the Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Am J Physiol Heart Circ Physiol. 2022 Apr 1;322(4):H579-H596. doi: 10.1152/ajpheart.00666.2021. Epub 2022 Feb 18.
During the past two decades, the field of mammalian myocardial regeneration has grown dramatically, and with this expanded interest comes increasing claims of experimental manipulations that mediate bona fide proliferation of cardiomyocytes. Too often, however, insufficient evidence or improper controls are provided to support claims that cardiomyocytes have definitively proliferated, a process that should be strictly defined as the generation of two de novo functional cardiomyocytes from one original cardiomyocyte. Throughout the literature, one finds inconsistent levels of experimental rigor applied, and frequently the specific data supplied as evidence of cardiomyocyte proliferation simply indicate cell-cycle activation or DNA synthesis, which do not necessarily lead to the generation of new cardiomyocytes. In this review, we highlight potential problems and limitations faced when characterizing cardiomyocyte proliferation in the mammalian heart, and summarize tools and experimental standards, which should be used to support claims of proliferation-based remuscularization. In the end, definitive establishment of de novo cardiomyogenesis can be difficult to prove; therefore, rigorous experimental strategies should be used for such claims.
在过去的二十年中,哺乳动物心肌再生领域发展迅速,随着人们对此领域兴趣的增加,越来越多的实验操作声称能介导心肌细胞的真正增殖。然而,往往没有提供足够的证据或适当的对照来支持心肌细胞已经明确增殖的说法,这个过程应该被严格定义为从一个原始心肌细胞产生两个全新的、有功能的心肌细胞。在整个文献中,人们发现应用的实验严谨性水平不一致,并且经常作为心肌细胞增殖证据提供的具体数据仅表明细胞周期的激活或 DNA 合成,而这并不一定导致新的心肌细胞的产生。在这篇综述中,我们强调了在描述哺乳动物心脏中心肌细胞增殖时面临的潜在问题和局限性,并总结了支持基于增殖的再肌化的工具和实验标准。最终,新的心肌发生的确立很难证明;因此,对于这样的说法应该使用严格的实验策略。